// App-Quantinova.ai

: Long-Term Follow-up of the Randomized Controlled Study in Patients with Newly Diagnosed Severe Aplastic Anemia Treated with ATG, Cyclosporine, with or without G-CSF: On Behalf of the SAA Working Party of the EBMT

Researchers

Presenter

  • Andr Tichelli

Principal Investigators

  • Regis Peffault De Latour

  • Jakob R. Passweg

  • Cora Knol

  • Grard Soci

  • Judith Marsh

  • Britta Hoechsmann

  • Hubert Schrezenmeier

  • Andrea Bacigalupo

  • Sujith Samarasinghe

  • Alicia Rovo

  • Austin G. Kulasekararaj

  • Dirk-Jan Eikema

  • Paul Bosman

  • Peter Bader

  • Antonio M. Risitano

  • Carlo Dufour

Medical Centers

  • Division of Endocrinology, University Hospital Basel, Basel, Switzerland

  • Hospital Saint Antoine, Paris, France

  • University Hospital, Hematology, Basel, Switzerland, Basel, Switzerland

  • EBMT Registry Office, Leiden, Netherlands

  • Department of Hematology and Transplantation Unit, APHP Saint Louis Hospital, Paris, France

  • Department of Haematological Medicine, King's College London, London, United Kingdom

  • Institute of Transfusion Medicine, University of Ulm, Germany ,

  • Hematology, Universit Cattolica del Sacro Cuore - Policlinico A. Gemelli, Roma, Italy

  • Great Ormond Street Hospital, London, United Kingdom

  • Hematology and Central Hematology Laboratory, Inselspital, University Hospital of Bern, Bern, Switzerland

  • Department of Haematological Medicine,King’s College Hospital, NIHR/Wellcome King’s Clinical Research Facility,London,United Kingdom

  • Department for Children and Adolescents, University Hospital Frankfurt, Frankfurt, Germany

  • Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy

  • Pediatric Hematology, Giannina Gaslini Childrens Hospital, Genova, Italy,

Locations

  • Switzerland

  • France

  • Netherlands

  • United Kingdom

  • Germany

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Aplastic anemia

Biomarkers

  • Serum amyloid A

Drug/Treatment

  • Cyclosporine eent

  • Filgrastim

Outcome

  • N/A

Study Design

  • Randomized

  • Multicenteric

  • Prospective

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved